Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, July 12, 2023
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
[ Wed, Jul 12th 2023
] - WOPRAI
Tue, July 11, 2023
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
[ Tue, Jul 11th 2023
] - WOPRAI
Matthew Korn Maintained (BNTX) at Hold with Decreased Target to $119 on, Jul 11th, 2023
Matthew Korn of Morgan Stanley, Maintained "BioNTech SE" (BNTX) at Hold with Decreased Target from $124 to $119 on, Jul 11th, 2023.
Matthew has made no other calls on BNTX in the last 4 months.
There are 9 other peers that have a rating on BNTX. Out of the 9 peers that are also analyzing BNTX, 5 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold with Decreased Target to $120 on, Thursday, May 18th, 2023
- Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $128 on, Monday, April 10th, 2023
- Eliana Merle of "UBS" Maintained at Hold with Decreased Target to $153 on, Friday, March 31st, 2023
- Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $140 on, Tuesday, March 28th, 2023
- Yaron Werber of "TD Cowen" Maintained at Hold with Decreased Target to $130 on, Tuesday, March 28th, 2023
These are the ratings of the 4 analyists that currently disagree with Matthew
- Bill Selesky of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $203 on, Friday, June 16th, 2023
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $181 on, Friday, June 9th, 2023
- Simon Baker of "Redburn Partners" Upgraded from Hold to Strong Buy and Increased Target to $170 on, Wednesday, May 17th, 2023
- Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Decreased Target to $194 on, Tuesday, March 28th, 2023
